Skip to main content

vTv Therapeutics Inc

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

VTVT$21.18+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

vTv THERAPEUTICS INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2025

PAGENUMBER
PART I – FINANCIAL INFORMATION
Item 1.Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 20244
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 20245
Unaudited Condensed Consolidated Statement of Changes in Redeemable Noncontrolling Interest and Stockholders’ Equity (Deficit) for the three months ended March 31, 2025 and 20246
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 20247
Notes to Unaudited Consolidated Financial Statements8
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations21
Item 3.Quantitative and Qualitative Disclosures About Market Risk28
Item 4.Controls and Procedures29
PART II – OTHER INFORMATION
Item 1.Legal Proceedings29
Item 1A.Risk Factors30
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds31
Item 3.Defaults Upon Senior Securities31
Item 4.Mine Safety Disclosures31
Item 5.Other Information31
Item 6.Exhibits31
Signatures32
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.